Cow Milk

In adult clinical practice, Cow Milk extracts are primarily used for diagnostic purposes.

• Skin Prick Testing (SPT): A single drop of the non-standardized extract (usually 1:20 w/v) is applied to the forearm or back, followed by a skin puncture. Results are read after 15–20 minutes.
• Oral Immunotherapy (OIT): While more common in children, adult OIT may involve a 'Rush' phase followed by a 'Build-up' phase. Dosing starts as low as 0.1 mg of milk protein and may escalate to a maintenance dose of 200–500 mg daily, depending on the patient's tolerance and the clinician's protocol.

Cow Milk protein allergy is most prevalent in the pediatric population.

• Diagnostic Testing: Same as adults, though the number of tests may be limited to reduce distress.
• Oral Immunotherapy (OIT): This is the primary therapeutic use.
• Initial Dose Escalation: Often performed in a single day in a clinical setting, starting at 0.01 mg to 0.1 mg of milk protein.
• Build-up Phase: Doses are increased every 1–2 weeks by 20–50% until a maintenance dose (e.g., 240 mg of protein, roughly equivalent to 8 mL of milk) is reached.
• Maintenance Phase: The target dose is consumed daily to maintain desensitization.

Renal Impairment

No specific dose adjustments are required for Cow Milk allergenic extracts in patients with renal impairment, as the systemic protein load is minimal. However, patients with end-stage renal disease should be monitored for fluid and electrolyte balance if using large volumes of milk-based medical foods.

Hepatic Impairment

No adjustments are typically necessary. The liver's role in processing the amino acids derived from milk proteins is usually sufficient unless the patient is in acute hepatic failure.

Elderly Patients

Elderly patients may have a higher prevalence of lactose intolerance, which is distinct from milk protein allergy. Clinical use of Cow Milk extracts should be preceded by a clear distinction between these two conditions. Dosing remains the same as for adults.

For diagnostic extracts, the application is performed exclusively by a healthcare professional. For Oral Immunotherapy (OIT):

• Consistency: The dose must be taken at the same time every day to maintain the desensitized state.
• Food: For OIT, the dose is often mixed with a 'vehicle' food (e.g., applesauce or pudding) that does not contain milk. It should not be taken on an empty stomach to reduce the risk of gastrointestinal side effects.
• Exercise Restriction: Patients must avoid exercise for 2 hours before and 2 hours after taking an OIT dose, as exercise can lower the threshold for anaphylaxis (Exercise-Induced Anaphylaxis).
• Storage: Extracts and OIT solutions should generally be refrigerated between 2°C and 8°C (36°F to 46°F) and kept away from light.

In OIT, a missed dose can be dangerous.

• One Missed Dose: Usually, the patient can take the next scheduled dose as normal.
• Two Missed Doses: The dose may need to be reduced.
• Three or More Missed Doses: Contact your allergist immediately. Do NOT resume the full dose at home, as the risk of anaphylaxis increases significantly when the immune system is not regularly 'primed.'

An overdose of Cow Milk in an allergic patient results in an allergic reaction or anaphylaxis.

• Signs: Hives, swelling of the throat, difficulty breathing, rapid pulse, dizziness, or vomiting.
• Emergency Measures: Administer epinephrine (EpiPen) immediately and call emergency services. In a clinical setting, healthcare providers will use antihistamines, corticosteroids, and fluids to manage the reaction.

> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose without medical guidance.

When Cow Milk is used as a therapeutic allergenic extract (OIT), side effects are very common as the body adjusts to the allergen.

• Oropharyngeal Itching: A 'tingling' or itchy sensation in the mouth or throat immediately after ingestion. This usually subsides within 30 minutes.
• Gastrointestinal Distress: Mild abdominal pain, cramping, or nausea. This is often described as a 'heavy' feeling in the stomach.
• Local Skin Reactions: In diagnostic testing, a red, itchy bump (wheal) at the site of the skin prick is the expected result, not a side effect.

• Urticaria (Hives): Scattered itchy welts on the skin, occurring within an hour of dosing.
• Angioedema: Localized swelling, often around the lips or eyes.
• Vomiting: A single episode of emesis shortly after a dose escalation.
• Nasal Congestion: Runny nose or sneezing (allergic rhinitis symptoms).

• Eosinophilic Esophagitis (EoE): A chronic immune-mediated condition where white blood cells (eosinophils) build up in the esophagus, causing difficulty swallowing or food impaction. This is a known risk of long-term oral immunotherapy.
• Severe Bronchospasm: Wheezing and significant difficulty breathing, particularly in patients with pre-existing asthma.
• Hypotension: A drop in blood pressure, often associated with systemic anaphylaxis.

> Warning: Stop taking Cow Milk extracts and call your doctor or emergency services immediately if you experience any of the following:

• Anaphylaxis: A systemic, life-threatening allergic reaction. It often starts with a sense of 'impending doom,' followed by swelling of the tongue, throat tightness, and a rapid drop in blood pressure.
• Difficulty Swallowing: Persistent pain or the feeling of food getting stuck in the chest, which may indicate the development of EoE.
• Loss of Consciousness: Fainting or extreme lightheadedness after a dose.
• Severe Chest Pain: Though rare, systemic reactions can put significant stress on the cardiovascular system.

The primary long-term concern with Cow Milk immunotherapy is the development of Eosinophilic Esophagitis (EoE). Studies suggest that approximately 2–5% of patients undergoing OIT for milk may develop EoE symptoms. Regular monitoring of swallowing function and gastrointestinal health is required. Additionally, long-term use of milk as an acidifying agent or calculi dissolution agent requires monitoring of bone mineral density, as chronic acidification can theoretically lead to calcium leaching from bones, although this is rarely seen with standard clinical extracts.

No FDA black box warnings for Cow Milk. However, all allergenic extracts carry a general warning regarding the risk of severe anaphylaxis and the requirement that they be administered in a facility equipped to handle life-threatening allergic emergencies.

Report any unusual symptoms to your healthcare provider, especially those that occur shortly after a dose change or during illness.

Cow Milk allergenic extracts are high-risk biological products. They must only be used under the supervision of a physician board-certified in Allergy and Immunology. Patients must be educated on the correct use of an epinephrine autoinjector before starting any Cow Milk-based immunotherapy. It is critical to distinguish between Cow's Milk Protein Allergy (an immune response) and Lactose Intolerance (an enzyme deficiency), as the treatments and risks are entirely different.

No FDA black box warnings for Cow Milk extracts. However, the FDA requires a 'General Warning' for all allergenic extracts: 'This product can cause severe systemic reactions, including anaphylaxis, which may be fatal. Patients should be observed for at least 30 minutes following administration.'

• Anaphylaxis Risk: The risk is highest during the initial dose escalation and build-up phases of OIT. Factors such as viral infection, menstruation, sleep deprivation, and uncontrolled asthma can lower the reaction threshold.
• Asthma Stability: Patients with poorly controlled asthma are at a significantly higher risk for fatal anaphylaxis. Cow Milk immunotherapy should be paused if asthma symptoms are active.
• Eosinophilic Esophagitis (EoE): Patients with a history of EoE or severe gastroesophageal reflux disease (GERD) should use Cow Milk extracts with extreme caution.
• Beta-Blocker Use: Patients taking beta-blockers may be resistant to the effects of epinephrine, making an allergic reaction much harder to treat.

• Spirometry/Peak Flow: Regular monitoring of lung function in asthmatic patients.
• Growth Monitoring: In children, regular height and weight checks to ensure that OIT or dietary restrictions are not impacting development.
• IgE/IgG4 Levels: Periodic blood tests (ImmunoCAP) to track the immunological shift and determine the likelihood of achieving 'sustained unresponsiveness.'
• Gastrointestinal Assessment: Monitoring for symptoms of EoE (heartburn, dysphagia).

Cow Milk itself does not cause impairment. However, if an allergic reaction occurs or if the patient takes an antihistamine to manage mild side effects, drowsiness may occur. Patients should not drive if they feel unwell after a dose.

Alcohol consumption should be avoided around the time of Cow Milk immunotherapy dosing. Alcohol increases gastric permeability and causes vasodilation, both of which can accelerate the absorption of the allergen and increase the risk of a systemic reaction.

Discontinuing Cow Milk OIT suddenly will result in the loss of desensitization. Within days to weeks, the patient will return to their baseline level of sensitivity, and accidental ingestion of milk could once again cause anaphylaxis. Tapering is not usually required for safety, but the clinical 'protection' disappears quickly.

> Important: Discuss all your medical conditions with your healthcare provider before starting Cow Milk therapy.

• Beta-Blockers (e.g., Propranolol, Atenolol): These are contraindicated during Cow Milk immunotherapy because they block the beta-adrenergic receptors that epinephrine needs to act upon during an anaphylactic emergency. This can make a reaction life-threatening and unresponsive to standard treatment.
• MAO Inhibitors (e.g., Phenelzine): These can interfere with the metabolism of endogenous and exogenous catecholamines, complicating the management of an allergic reaction.

• ACE Inhibitors (e.g., Lisinopril): These drugs may increase the severity of anaphylactic reactions by interfering with the degradation of kinins, which are involved in the inflammatory response.
• Tricyclic Antidepressants (TCAs): Similar to MAOIs, TCAs can potentiate the effects of epinephrine but also complicate the cardiovascular response during a systemic reaction.

• Antihistamines (e.g., Cetirizine, Loratadine): These will interfere with the results of diagnostic skin prick testing. They must be discontinued for 3–7 days prior to testing. In the context of OIT, they may mask early warning signs of a reaction.
• Proton Pump Inhibitors (PPIs): By raising gastric pH, PPIs may slow the digestion of milk proteins, potentially altering their allergenicity and the timing of a reaction.

• High-Fat Meals: Taking a Cow Milk OIT dose with a very high-fat meal may delay absorption, potentially causing a 'late' allergic reaction several hours after the dose.
• Hot Beverages: Consuming very hot liquids immediately after a dose can increase local blood flow in the mouth and throat, worsening oropharyngeal itching.

• St. John's Wort: May theoretically affect the metabolism of medications used to treat allergic reactions, though the clinical significance is low.
• Probiotics: Some studies suggest that specific probiotics (e.g., Lactobacillus rhamnosus) may synergize with Cow Milk OIT to improve desensitization rates, but this should only be done under medical supervision.

• Skin Prick Tests: Cow Milk extract administration will obviously affect subsequent skin tests.
• Serum IgE: Total and specific IgE levels will fluctuate during treatment.
• Urinary pH: Due to its Acidifying Activity [MoA], Cow Milk may lower urinary pH, which can interfere with tests for certain metabolic disorders or drug screenings that are pH-dependent.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

• Severe, Uncontrolled Asthma: Patients with an FEV1 consistently below 80% of predicted or those with frequent exacerbations must not undergo Cow Milk immunotherapy. The risk of fatal bronchospasm during a reaction is too high.
• History of Severe Anaphylaxis to Trace Amounts: Patients who have experienced life-threatening reactions to microscopic cross-contamination may be considered too high-risk for OIT.
• Active Eosinophilic Esophagitis (EoE): Since OIT can cause or worsen EoE, a pre-existing diagnosis is an absolute contraindication for the oral route.
• Inability to Use Epinephrine: Patients with physical or mental limitations that prevent them or their caregivers from administering epinephrine safely.

• Severe Atopic Dermatitis: If the skin is too inflamed, diagnostic skin testing may be impossible to interpret, and systemic treatment may cause significant flares.
• Cardiovascular Disease: Patients with significant heart disease may not tolerate the stress of a systemic reaction or the epinephrine used to treat it.
• Autoimmune Disorders: The impact of chronic allergen stimulation on systemic autoimmune conditions is not well-studied.

• Goat and Sheep Milk: There is a high degree of cross-reactivity (up to 90%) between cow milk proteins and those from goats and sheep. Patients allergic to Cow Milk extracts will almost certainly react to these as well.
• Beef: A small percentage of milk-allergic patients (about 10%) may also be sensitive to bovine serum albumin found in beef, though this is usually lost when the meat is cooked.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Cow Milk extracts.

Cow Milk extracts are generally categorized as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women.

• Diagnostic Testing: Should be deferred until after delivery unless the information is critical for immediate management.
• Immunotherapy (OIT): It is generally recommended not to start OIT during pregnancy due to the risk of anaphylaxis, which can cause fetal hypoxia (lack of oxygen). However, if a woman is already on a stable maintenance dose, many allergists allow her to continue, as the risk of a reaction is lower on maintenance than during the build-up phase.

Cow Milk proteins and their metabolites are naturally present in human breast milk if the mother consumes dairy.

• Nursing Mothers of Allergic Infants: If a nursing infant has a severe Cow's Milk Protein Allergy, the mother may need to avoid Cow Milk extracts and dietary milk, as the proteins can pass through breast milk and cause symptoms in the infant (e.g., proctocolitis).
• Safety: For the mother herself, Cow Milk extracts are safe to use while breastfeeding if she is not allergic.

This is the primary population for Cow Milk allergenic extracts.

• Approval: FDA-cleared for use in children as young as infants for diagnostic purposes.
• OIT: Most OIT research and clinical practice focus on children aged 4 to 17.
• Growth: There is no evidence that Cow Milk extracts for OIT interfere with growth; in fact, successful desensitization often allows for a more diverse and nutritionally complete diet.

• Renal Function: While Cow Milk proteins don't require renal clearance, the calcium-chelating and acidifying properties must be monitored in elderly patients with declining kidney function to avoid electrolyte imbalances.
• Polypharmacy: The elderly are more likely to be on beta-blockers or ACE inhibitors, which are major contraindications for allergenic extract use.

In patients with chronic kidney disease (CKD), the use of Cow Milk as a Calculi Dissolution Agent [EPC] must be carefully managed. The phosphorus content in milk proteins can be problematic for patients who need to limit phosphorus intake to manage secondary hyperparathyroidism.

No specific adjustments are needed. However, in cases of severe hepatic encephalopathy, the protein load from Cow Milk-based medical foods must be monitored, as it contributes to ammonia production (Ammonium Ion Binding Activity [MoA] is a relevant factor here).

> Important: Special populations require individualized medical assessment.

At the molecular level, Cow Milk allergenic extracts contain specific proteins: Bos d 8 (Caseins), Bos d 4 (Alpha-lactalbumin), and Bos d 5 (Beta-lactoglobulin).

1. 1Diagnostic Action: These proteins bind to IgE antibodies on mast cells. This triggers the FcεRI receptor signaling pathway, leading to the release of pre-formed mediators like histamine.
2. 2Immunotherapeutic Action: Chronic, low-level exposure leads to the induction of T-regulatory (Treg) cells which secrete IL-10 and TGF-beta. These cytokines suppress the Th2 allergic response and induce B-cells to switch from IgE production to IgG4 production. IgG4 acts as a competitive inhibitor, binding the milk protein before it can reach the IgE on mast cells.
3. 3Biochemical Action: The Calcium Chelating Activity [MoA] occurs via the phosphoserine residues on casein, which sequester calcium ions, preventing the formation of insoluble calcium salts.

• Onset of Action: Skin prick reactions occur within 15–20 minutes. Immunological changes (IgG4 rise) take 3–6 months of daily OIT.
• Duration of Effect: Desensitization is transient. If the 'drug' (milk protein) is stopped, the desensitized state typically fades within weeks (loss of 'sustained unresponsiveness').
• Dose-Response: There is a clear dose-response relationship in OIT; higher maintenance doses generally provide better protection against accidental exposure but carry a higher risk of gastrointestinal side effects.

| Parameter | Value |

|---|---|

| Bioavailability | <1% (Intact allergenic proteins) |

| Protein Binding | N/A (Is a protein mixture) |

| Half-life | 2–4 hours (Peptide fragments) |

| Tmax | 1–2 hours (Post-ingestion) |

| Metabolism | Gastrointestinal Proteolysis |

| Excretion | Renal (Nitrogenous waste) |

• Molecular Structure: A complex mixture of phosphoproteins (caseins) and globular proteins (whey).
• Solubility: Caseins are insoluble at pH 4.6 (isoelectric point) but soluble in clinical buffered saline extracts.
• Drug Class: Non-Standardized Food Allergenic Extract [EPC].

Cow Milk belongs to the Allergenic Extracts therapeutic class. It shares this space with other food extracts (Peanut, Egg, Wheat) and environmental extracts (Dust Mite, Ragweed). It is unique for its additional classifications as a Methylxanthine [EPC] (in specific derivatives) and Calculi Dissolution Agent [EPC].